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ABSTRACT
Background and aims: Fatigue is associated with longitudinal
ratings of health in patients with chronic obstructive pul-
monary disease (COPD). Although the degree of airflow
obstruction is often used to grade disease severity in patients
with COPD, multidimensional grading systems have recently
been developed. The aim of this study was to investigate the
relationship between perceived and actual fatigue level and
multidimensional disease severity in patients with COPD. 
Materials and methods: Twenty-two patients with COPD (aged
52-74 years) took part in the study. Multidimensional disease
severity was measured using the SAFE and BODE indices.
Perceived fatigue was assessed using the Fatigue Severity Scale
(FSS) and the Fatigue Impact Scale (FIS). Peripheral muscle
endurance was evaluated using the number of sit-ups, squats,
and modified push-ups that each patient could do. 
Results: Thirteen patients (59%) had severe fatigue, and their
St George’s Respiratory Questionnaire scores were signifi-
cantly higher (p < 0.05). The SAFE index score was significant-
ly correlated with the number of sit-ups, number of squats,
FSS score and FIS score (p < 0.05). The BODE index was signif-
icantly associated with the numbers of sit-ups, squats and
modified push-ups, and with the FSS and FIS scores (p < 0.05). 
Conclusions: Peripheral muscle endurance and fatigue perception
in patients with COPD was related to multidimensional disease
severity measured with both the SAFE and BODE indices.
Improvements in perceived and actual fatigue levels may posi-
tively affect multidimensional disease severity and health status
in COPD patients. Further research is needed to investigate the
effects of fatigue perception and exercise training on patients
with different stages of multidimensional COPD severity. 
Keywords: BODE index, COPD, disease severity, endurance,
fatigue, SAFE index. 
RIASSUNTO 
Razionale e scopo dello studio: La sensazione di fatica si colle-
ga, nella valutazione longitudinale dello stato di salute, con la
broncopneumopatia cronica ostruttiva (BPCO). Sebbene il li-
vello di ostruzione del flusso delle vie aeree sia spesso utiliz-
zato per stratificare la gravità di malattia nella BPCO, sono
stati recentemente sviluppati sistemi di stadiazione multidi-
mensionali. Scopo di questo studio è indagare il rapporto tra
il livello di fatica percepito e reale con il livello di gravità mul-
tidimensionale nei pazienti con BPCO. 
Materiali e metodi: 22 pazienti con BPCO (età 52-74 anni) hanno
preso parte allo studio. Gli indici SAFE e BODE sono stati utiliz-
zati per valutare in modo multidimensionale la gravità di malat-
tia. La fatica percepita è stata valutata con le scale FSS (Fatigue
Severity Scale) e FIS (Fatigue Impact Scale). La resistenza dei
muscoli periferici è stata indagata con il numero di ripetizioni
degli esercizi seduto-in piedi, flessione sulle gambe e solleva-
mento modificato che ogni paziente era in grado di sostenere.
Risultati: 13 pazienti (59%) hanno riferito grave fatica e il loro
punteggio al St George’s Respiratory Questionnaire era signi-
ficativamente più elevato (p < 0,05). Il punteggio dell’indice
SAFE era correlato in modo significativo con il numero di ripe-
tizioni degli esercizi seduto-in piedi, flessione sulle gambe e
sollevamento modificato e con i punteggi FSS e FIS (p < 0,05). 
Conclusioni: La resistenza dei muscoli periferici e la percezio-
ne di fatica nei pazienti con BPCO è risultata correlata con il
livello di gravità multidimensionale della patologia stimata
sia con l’indice SAFE che col BODE. I miglioramenti nei livelli
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di fatica percepiti e reali possono perciò avere conseguenze
positive sul quadro multidimensionale di gravità della malat-
tia e sulla condizione di salute nei pazienti con BPCO. Ulteriori
ricerche sono necessarie per valutare gli effetti della perce-
zione di fatica e del riallenamento allo sforzo in pazienti con
differenti stadi di gravità multidimensionale della BPCO.
Parole chiave: BPCO, indice BODE, indice SAFE, fatica, gravità
di malattia, resistenza. 
INTRODUCTION
Fatigue is the perception of mental or physical
exhaustion due to exertion [1]. In addition to dysp-
nea, fatigue is one of the dominant symptoms that
impairs exercise capacity and functional status in
patients with chronic obstructive pulmonary disease
(COPD), which is a slowly progressive disease char-
acterized by irreversibly impaired pulmonary func-
tion [2]. The presence of COPD is associated with
impaired muscle endurance [3]. COPD patients with
increased fatigue frequently have more functional
limitations [4] and worse current [2,4] and longitudi-
nal health ratings [1].
The staging system to assess COPD severity is based
on airflow obstruction and is expressed as a per-
centage of the predicted value for the forced expira-
tory volume in one second (FEV1) [5]. Studies have
found that the degree of airflow limitation is closely
related to mortality [6]. However, FEV1 does not
reflect the systemic involvement [7] and does not
provide an overall assessment of COPD severity [8]. 
Recently, multidimensional grading systems (BODE
and SAFE indices) have been developed to assess
both pulmonary and systemic manifestations of
COPD. Both indices incorporate different domains
quantifying the characteristics of COPD to provide
a more holistic stratification of disease severity
[7,8]. The BODE index includes pulmonary impair-
ment (FEV1), symptoms (modified Medical Research
Council dyspnea scale, MMRC), exercise capacity
(six-minute walk test, 6MWT) and nutritional state
(body mass index). BODE index scores have been
shown to correlate well with the rate of COPD hos-
pitalization [9] and survival [7]. A newer index, the
SAFE index, incorporates a standardized health-
related quality of life assessment tool, St George’s
Respiratory Questionnaire (SGRQ), in addition to
6MWT distance and FEV1 [8]. 
Despite conceptual change in COPD staging, to our
knowledge no previous study has investigated
whether there is an association between fatigue, a
common disabling symptom, and these more holis-
tic approaches to the measurement of COPD dis-
ease severity. Therefore, the aim of this study was to
investigate the relationship between perceived and
actual fatigue level and multidimensional disease
severity (respiratory symptoms and systemic conse-
quences) in patients with clinically stable COPD. 
MATERIALS AND METHODS
Twenty-two male patients with clinically stable
COPD (aged 52-74 years) took part in the study. The
diagnosis of COPD, made by a pulmonologist, was
based on medical history, current symptoms, and
pulmonary function testing following the Global
Initiative for Chronic Obstructive Pulmonary
Disease (GOLD) Guidelines [5]. Subjects who had
significant musculoskeletal or cardiovascular con-
ditions were excluded. All subjects provided their
written consent for the study, which was approved
by the Hacettepe University Ethics Committee. 
Age, gender, height, weight, time from diagnosis,
and smoking history were all recorded. Body mass
index was calculated as kg/m2. Subjects underwent
pulmonary function testing using a spirometer
(Spirolab, Medical International Research, Rome,
Italy). Forced vital capacity (FVC), FEV1, peak expi-
ratory flow rate (PEF), and forced expiratory flow
between 25% and 75% of FVC (FEF25-75%) were
expressed as percentages of the predicted values [10].
Dyspnea was evaluated using the MMRC dyspnea
scale [11]. Exercise tolerance was assessed using the
6MWT [12]. Quality of life was determined using the
SGRQ, with total scores ranging from 1 to 100, where
100 indicates the worst health [13]. 
Perceived fatigue was assessed using the Fatigue
Severity Scale (FSS) and the Fatigue Impact Scale
(FIS). The FSS is a 9-item scale measuring the sever-
ity of fatigue. The total score ranges from 1 to 7.
Scores ≥ 4 indicate severe fatigue [14]. The FIS scale
is a 40-item, three-dimensional (cognitive, physical,
and psychosocial function) scale measuring the
effects of fatigue on daily living activities and the
quality of life [15]. Scores range from 0 to 160, and
a higher score reflects a greater impact of fatigue.
Peripheral muscle endurance was evaluated using
the number of sit-ups (trunk endurance), squats
(lower extremity endurance), and modified push-
ups (upper extremity endurance) that patients could
do in 30 seconds [16]. 
Multidimensional disease severity was measured
using the SAFE and BODE indices. The SAFE index
consists of the SGRQ score, FEV1, and 6MWT dis-
tance [8]. The maximum possible score is 9. The
SAFE index has four stages: stage I (score 0-2), stage
II (score 3-4), stage III (score 5-6), and stage IV
(score 7-9). The BODE index incorporates FEV1,
MMRC score, 6MWT distance, and body mass
index [7]. Scores range from 0 to 10. The BODE
index has four severity stages: stage I (score 0-2),
stage II (score 3-4), stage III (score 5-7), and stage IV
(score 8-10). In both indices, higher scores indicate
increased COPD severity. 
Statistical analysis was performed using the
Statistical Package for Social Sciences (SPSS) ver-
sion 15.0 [17]. Data are presented as mean ± SD
unless specified. To determine the relationship
between disease severity and fatigue, Spearman
rank correlation coefficients were used. Statistical
significance was defined as a value of p < 0.05. 
RESULTS
According to the GOLD classification, 5 patients
had mild COPD, 4 had moderate COPD, 6 had
severe COPD, and 7 had very severe COPD. The
mean time from diagnosis was 10.9 ± 7.7 years. The
mean level of cigarette smoking was 46.3 ± 24.9
pack-years. Patient characteristics are presented in
Tables I and II. The FSS scores showed that 13
patients (59%) with COPD had severe fatigue.
These patients’ total SGRQ score was significantly
higher than that of the patients with less severe
fatigue (p = 0.030). 
Percentage of the predicted FEV1 was significantly
correlated with the number of sit-ups, squats, and
push-ups done (Table III). FEV1 was also significant-
ly associated with the total FIS score (r = -0.55), the
FIS physical score (r = -0.56), FIS cognitive score (r
= -0.43), and FIS psychosocial score (r = -0.52, 
p < 0.05). When patients were classified according
to the GOLD severity classification system, the
patient’s GOLD stage was significantly associated
with the number of sit-ups, squats and push-ups
done (Table III), and with the FSS score (r = 0.56),
total FIS score (r = 0.52), FIS physical score 
(r = 0.54), and FIS psychosocial score (r = 0.49, 
p < 0.05). 
Six patients (27.3%) were in SAFE stage I, 8 patients
(36.4%) were stage II, 4 patients (18.2%) were stage
III, and 4 patients (18.2%) were stage IV. The SAFE
index score was significantly correlated with the
number of sit-ups, number of squats, the FSS score
and the total FIS score (p < 0.05, Table III, Figure 1).
TABLE I: PATIENT CHARACTERISTICS  
Variable
Age (years) 62.5 ± 6.5
Body mass index (kg/m2) 26.0 ± 4.4
FEV1 (% pred.) 49.7 ± 28.5
FVC (% pred.) 66.0 ± 23.9
PEF (% pred.) 56.1 ± 28.8
FEF25-75% (% pred.) 29.6 ± 23.4
MMRC (0-4) 1.82 ± 0.96
6MWT distance (m) 506.3 ± 128.0
SGRQ (0-100) 50.9 ± 22.3
SAFE index score (0-9) 3.7 ± 2.5
BODE index score (0-10) 2.9 ± 2.1
FSS (0-7) 4.52 ± 1.89
FIS (0-160) 32.9 ± 31.3
Sit-ups (n) 17.4 ± 6.1
Squats (n) 16.5 ± 4.6
Push-ups (n) 17.2 ± 6.9
Definition of abbreviations: FEF25-75%, forced expiratory flow between
25% and 75% of FVC; FEV1, forced expiratory volume in one second;
FIS, Fatigue Impact Scale; FSS, Fatigue Severity Scale; FVC, forced
expiratory volume in one second; MMRC, modified Medical Research
Council dyspnea scale; 6MWT, six minute walk test; PEF, peak 
expiratory flow rate; SGRQ, St George’s Respiratory Questionnaire.
TABLE II: INDIVIDUAL VALUES FOR ALL PARAMETERS FOR EACH OF THE 22 COPD PATIENTS 
No Age BMI Time Smoking FEV1 FVC FEV1/ PEF FEF25-75% MMRC 6MWT SGRQ SAFE BODE FSS FIS Sit-ups Squats Push-
from history FVC ups
diagnosis
1 74 22.2 15 0 57 65 68 3 38 2 404 56.2 3 2 5.67 20 - - -
2 63 25.2 2 35 57 80 75.9 38 25 2 466 56.2 3 2 5.56 12 - 10 -
3 52 25.2 10 45 61 77 63.9 64 28 1 716 40.4 2 1 5.00 1 15 20 17
4 52 32.7 15 52.5 47 85 44 57 19 2 654 65.5 5 3 2.00 115 15 18 25
5 64 28.8 10 40 52 61 67.8 55 25 1 529 72.9 4 1 2.89 16 13 15 14
6 56 24.1 14 25 26 46 45 45 14 2 600 83.8 6 4 5.78 54 21 16 16
7 70 31.5 8 40 16 38 33.5 29 9 3 316 70.9 7 6 6.22 36 - - -
8 71 29.4 20 50 35 64 43.1 75 16 1 512 31.8 3 3 6.00 76 16 13 12
9 53 24.5 7 67.5 34 48 54.2 49 19 1 563 45.9 3 3 5.44 44 11 - -
10 58 27.5 4 75 22 37 46.8 29 9 3 382 72.1 7 5 6.78 76 11 13 -
11 64 23.9 7 40 41 52 62.2 63 18 3 434 76.6 5 4 5.67 55 8 12 1
12 62 22.6 8 24 25 46 57 20 14 3 583 52.2 5 5 6.78 16 10 12 9
13 59 32.4 9 80 36 62 46.2 51 13 1 532 55.9 4 2 4.78 20 - 12 -
14 63 20.6 30 53 23 51 34.7 27 11 3 171 86.1 9 8 7.00 81 - - -
15 55 21.0 30 30 23 40 47.8 30 13 1 558 30.1 4 3 1.56 1 21 15 19
16 68 30.6 13 32 38 43 68.9 43 23 1 456 39.3 3 2 3.67 8 23 27 23
17 63 17.4 4 103 22 51 33.8 28 11 3 392 67.4 7 6 1.67 35 12 14 13
18 65 25.5 3 42 98 97 78.6 128 82 2 620 32.3 1 1 6.22 6 23 24 25
19 61 22.5 11 80 94 110 66.8 89 55 1 601 29.5 0 0 3.67 11 18 16 14
20 62 26.3 1 60 95 99 76.6 86 69 0 633 14.4 0 0 1.89 11 27 20 25
21 65 25.0 8 45 104 113 72 119 67 1 612 9.7 0 0 1.44 0 25 21 23
22 74 34.4 10 0 87 87 77.3 56 73 3 404 30.7 1 2 3.67 30 26 19 22
Definition of abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; FEF25-75%, forced expiratory flow between
25% and 75% of FVC; FEV1, forced expiratory volume in one second; FIS, Fatigue Impact Scale; FSS, Fatigue Severity Scale; FVC, forced expi-
ratory volume in one second; MMRC, modified Medical Research Council dyspnea scale; 6MWT, six minute walk test; PEF, peak expiratory































The FIS physical (r = 0.67), cognitive (r = 0.51), and
psychosocial (r = 0.64) scores were also significant-
ly associated with the SAFE index (p < 0.05). There
were 11 patients (50%) in BODE stage I, 6 patients
(27.3%) in stage II, 4 patients (18.2%) in stage III,
and 1 patient (18.2%) in stage IV. The BODE index
score was significantly correlated with the number
of sit-ups, squats and push-ups; the FSS score; and
the total FIS score (p < 0.05, Table III, Figure 1). The
FIS physical (r = 0.73), cognitive (r = 0.58) and psy-
chosocial (r = 0.68) scores were also significantly
associated with the BODE index (p < 0.05). 
Only the FIS total and FIS physical scores were sig-
nificantly correlated with the number of sit-ups 
(r = -0.51 and r = -0.52, respectively) and the num-
ber of squats (r = -0.51 and r = -0.56, respectively,
p < 0.05). 
DISCUSSION 
The findings of this study show that peripheral mus-
cle endurance and fatigue perception are related to
multidimensional disease severity measured using
either the SAFE or BODE index in patients with clin-
TABLE III: RELATIONSHIP BETWEEN PERIPHERAL MUSCLE ENDURANCE AND DISEASE SEVERITY MEASURES  
Variable FEV1 GOLD SAFE BODE FSS FIS
Sit-ups (n) 0.59* -0.69* -0.68* -0.67* -0.43 -0.51*
Squats (n) 0.56* -0.59* -0.48* -0.57* -0.37 -0.51*
Push-ups (n) 0.56* -0.62* -0.43 -0.55* -0.37 -0.39
Definition of abbreviations: FEV1, forced expiratory volume in one second; FIS, Fatigue Impact Scale; FSS, Fatigue Severity Scale; GOLD,
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FIGURE 1: RELATIONSHIP BETWEEN MULTIDIMENSIONAL DISEASE SEVERITY INDICES (BODE AND SAFE INDICES) 
AND PERCEIVED FATIGUE MEASURES
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ically stable COPD. Physical fatigue was associated
with peripheral muscle endurance. 
According to previous findings, 47% to 58% of
patients with COPD report fatigue everyday
[18,19], and 44% of patients report that their
fatigue is the worst symptom that they perceive
[19]. We found that 59% of our patients had severe
fatigue, suggesting that fatigue is a prevalent symp-
tom in patients with clinically stable COPD. These
patients with severe fatigue had significantly higher
SGRQ scores than patients with less severe fatigue,
indicating that greater perception of fatigue was
associated with a greater subjective influence of the
disease on the patient’s quality of life [2,4]. Fatigue
might play a role in the vicious circle, with more
functional limitations and worse health perception
[2]. Increased fatigue should be taken into account
in clinical practice because fatigue has a notable
impact on both current [2,4] and future [1] health
ratings in patients with COPD.
In the current study, decreased FEV1 was associated
with increased severity and impact of fatigue in
COPD patients. We found that the physical, cogni-
tive, and psychosocial dimensions of fatigue were
affected by the severity of the airflow obstruction in
our COPD patients. In previous studies, fatigue has
been shown to be associated with the severity of air-
flow obstruction [4,20-22]. It is likely that the
increased severity of pulmonary impairment affects
the subjective perception of fatigue and of every
aspect of daily life in patients with mild to severe
COPD. In addition to physical fatigue [22], cogni-
tive and psychosocial fatigue might also benefit
from treatments targeting airflow limitations in
COPD patients. 
Reduced peripheral muscle (especially trunk and
lower extremity) endurance was associated with an
increase in the severity of pulmonary impairment
measured using FEV1. Skeletal muscle endurance
has been shown to be reduced in patients with
COPD [3,23,24], and it develops even in early
stages of COPD [3]. Impaired quadriceps
endurance is associated with the degree of airflow
obstruction (i.e. FEV1) [3,23], and it is related to an
increased susceptibility to peripheral muscle fatigue
in patients with COPD [24]. Muscle endurance
cannot be predicted from disease severity or muscle
strength [24]. Therefore, muscle endurance should
be measured using an appropriate apparatus
[3,23,24] or field test, similar to the one used in the
current study. Our results confirmed those of previ-
ous reports suggesting that peripheral muscle
endurance is reduced from the early stages of dis-
ease and that it is related to the severity of the dis-
ease measured using FEV1. Peripheral muscle
endurance, especially lower body and trunk
endurance, was shown to be related to composite
scores of disease severity. We also showed that only
physical fatigue was significantly correlated with
trunk and lower extremity peripheral muscle
endurance. This finding is probably due to the more
common use of these body parts in daily activities,
such as walking, in COPD patients.
With use of two multidimensional staging systems,
we showed that multidimensional disease severity
measured using either the BODE or SAFE indices
was associated with the severity and impact of
fatigue. In a previous study investigating the factors
contributing to the perception of health, Nguyen et
al. showed no association between BODE index
scores and fatigue. They used a 4-item one-dimen-
sional scale [1] reflecting the general intensity and
the frequency of fatigue [20]. The use of multi -
dimensional scales has been proposed to ensure a
complete description of the fatigue experience of
patients [21]. Multidimensional fatigue measures
seek to explore a wider experience of fatigue with
the inclusion of several factors. In our study, the
similarity of the correlations between actual and
subjective fatigue, which are potentially modifiable
factors, and the BODE and SAFE indices suggests
that both indices capture the adverse effects
induced by fatigue beyond the FEV1 and that both
scales can be used in clinical practice.
Multidimensional disease severity assessment,
which addresses multiple characteristics and mani-
festations of COPD and its impact on function, is
more informative than the severity of air flow
obstruction alone. 
In conclusion, we showed for the first time in the lit-
erature that peripheral muscle endurance and
fatigue perception in patients with COPD is related
to multidimensional disease severity measured
using either the SAFE or BODE indices, which go
beyond the severity of air flow limitation (i.e. FEV1).
Comparison of fatigue perception in patients at dif-
ferent stages of multidimensional disease severity
should be investigated using wider samples in each
stage. Further research is also needed to investigate
the effects of fatigue perception and exercise train-
ing in patients with different stages of multidimen-
sional COPD severity. Whether improvements in
perceived and actual fatigue levels may positively
affect multidimensional disease severity and health
status in these patients should be investigated.
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